Key result
Retnla deficiency significantly improved survival (P=0.036) and preserved left ventricular ejection fraction following myocardial infarction in mice by suppressing cardiomyocyte apoptosis and increasing angiogenesis.
Why the study?
Resistin-like alpha modulates fibrosis and inflammation, but its role in cardiac injury was not established.
Retnla deficiency improves cardiac repair and function post-myocardial infarction by suppressing apoptosis and promoting a proliferative, adiponectin-rich bone marrow niche.
Retnla targeting should not yet change post-MI care; hypothesis-generating for cardiac repair pathways in humans.
Resistin-like alpha (Retnla) is a member of the resistin family and known to modulate fibrosis and inflammation. Here, we investigated the role of Retnla in the cardiac injury model. Myocardial infarction (MI) was induced in wild type (WT), Retnla knockout (KO), and Retnla transgenic (TG) mice. Cardiac function was assessed by echocardiography and was significantly preserved in the KO mice, while worsened in the TG group. Angiogenesis was substantially increased in the KO mice, and cardiomyocyte apoptosis was markedly suppressed in the KO mice. By Retnla treatment, the expression of p21 and the ratio of Bax to Bcl2 were increased in cardiomyocytes, while decreased in cardiac fibroblasts. Interestingly, the numbers of cardiac macrophages and unsorted bone marrow cells (UBCs) were higher in the KO mice than in the WT mice. Besides, phosphorylated histone H3(+) cells were more frequent in bone marrow of KO mice. Moreover, adiponectin in UBCs was notably higher in the KO mice compared with WT mice. In an adoptive transfer study, UBCs were isolated from KO mice to transplant to the WT infarcted heart. Cardiac function was better in the KO-UBCs transplanted group in the WT-UBCs transplanted group. Taken together, proliferative and adiponectin-rich bone marrow niche was associated with substantial cardiac recovery by suppression of cardiac apoptosis and proliferation of cardiac fibroblast.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) studied Myocardial Infarction. Retnla deficiency (Knockout) vs. Wild-type mice was evaluated on Survival rate and left ventricular ejection fraction at 14 days post-myocardial infarction (p=0.036). Retnla deficiency significantly improved survival (P=0.036) and preserved left ventricular ejection fraction following myocardial infarction in mice by suppressing cardiomyocyte apoptosis and increasing angiogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Cell Death and Disease